Suchergebnisse - "Fabi, A"

PubPharm (11)

1

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer : an Italian multicenter observational study

enthalten in: ESMO open | 2021

von Schettini, F. | Conte, B. | Buono, G. | +25

2

Metastatic or locally advanced breast cancer patients : towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Cazzaniga, M. | Ciruelos, E. | Fabi, A. | +9

3

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients : New insights beyond clinical trials. The EVA study

enthalten in: Breast (Edinburgh, Scotland) | 2017

von Cazzaniga, M. | Airoldi, M. | Arcangeli, V. | +68

4

Effect of adjuvant trastuzumab treatment in conventional clinical setting : an observational retrospective multicenter Italian study

enthalten in: Breast cancer research and treatment | 2013

von Campiglio, M. | Bufalino, R. | Sasso, M. | +17

5

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer

enthalten in: British journal of cancer | 2012

von Minuti, G. | Cappuzzo, F. | Duchnowska, R. | +15

6

Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Gori, S. | Montemurro, F. | Spazzapan, S. | +12

7

New target therapies for brain metastases from breast cancer

enthalten in: Current cancer drug targets | 2012

von Metro, G. | Fabi, A.

8

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer : safety and efficacy in an open-label study in 2,251 patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Smith, I. | Pierga, J. | Biganzoli, L. | +18

9

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Metro, G. | Foglietta, J. | Russillo, M. | +9

10

Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis

enthalten in: European journal of cancer (Oxford, England : 1990) | 2006

von Merola, R. | Mottolese, M. | Orlandi, G. | +6